Big Insurers Reduce Medicare Advantage Coverage Amid Upcoming Enrollment Period
ByAinvest
Wednesday, Oct 1, 2025 5:06 pm ET1min read
CVS--
According to a Reuters report, CVS Health's Aetna insurance business will operate prescription drug plans in 100 fewer counties than in 2025, while Humana will cut plans back to 85% of U.S. counties next year, down from 89% in 2025 [1]. Both companies provide these plans on behalf of the U.S. government.
The companies are also reducing their operations by state. Humana will provide plans in 46 states in 2026, down from 48 this year, while Aetna will operate in 43 states and Washington D.C. and 2,159 counties for 2026, down from 44 states and 2,259 counties in 2025 [1].
Humana plans to introduce new plan types in four states and 177 counties, and 83% of stand-alone prescription drug plans for 2026 will carry decreased premiums. For people who qualify for both Medicare and Medicaid plans, CVS Health will expand offerings to 16 new states.
George Renaudin, president of insurance at Humana, stated, "For decades, Humana has been dedicated to making healthcare easy to navigate for Medicare beneficiaries, offering clear and consistent options that prioritize stability, quality, and affordability" [1].
These strategic adjustments reflect the ongoing challenges insurers face in managing Medicare Advantage plans, particularly in less profitable markets. The companies' decisions to reduce their footprint may indicate a shift in focus towards more cost-effective and competitive regions.
HUM--
UnitedHealthcare, Humana, and CVS Health have scaled back their Medicare Advantage offerings ahead of the next Medicare Open Enrollment period. UnitedHealthcare will exit 1,150 counties, Humana will exit 156 counties, and CVS Health will exit 1,736 counties. This move is likely due to the increasing competition and cost pressures in the Medicare Advantage market.
UnitedHealthcare, Humana, and CVS Health have announced significant reductions in their Medicare Advantage offerings ahead of the upcoming Medicare Open Enrollment period. UnitedHealthcare will exit 1,150 counties, Humana will exit 156 counties, and CVS Health will exit 1,736 counties. These moves are likely driven by increasing competition and cost pressures in the Medicare Advantage market.According to a Reuters report, CVS Health's Aetna insurance business will operate prescription drug plans in 100 fewer counties than in 2025, while Humana will cut plans back to 85% of U.S. counties next year, down from 89% in 2025 [1]. Both companies provide these plans on behalf of the U.S. government.
The companies are also reducing their operations by state. Humana will provide plans in 46 states in 2026, down from 48 this year, while Aetna will operate in 43 states and Washington D.C. and 2,159 counties for 2026, down from 44 states and 2,259 counties in 2025 [1].
Humana plans to introduce new plan types in four states and 177 counties, and 83% of stand-alone prescription drug plans for 2026 will carry decreased premiums. For people who qualify for both Medicare and Medicaid plans, CVS Health will expand offerings to 16 new states.
George Renaudin, president of insurance at Humana, stated, "For decades, Humana has been dedicated to making healthcare easy to navigate for Medicare beneficiaries, offering clear and consistent options that prioritize stability, quality, and affordability" [1].
These strategic adjustments reflect the ongoing challenges insurers face in managing Medicare Advantage plans, particularly in less profitable markets. The companies' decisions to reduce their footprint may indicate a shift in focus towards more cost-effective and competitive regions.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet